Regeneron Pharmaceuticals, Inc. (REGN) stock
REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$957.76+5.36 (+0.56%)
Close on Nov 17, 2026Market cap $99.08BP/E 21.2Yield –
Regeneron Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Regeneron Pharmaceuticals's market cap was $102.80B on Nov 11, 2026, against $85.94B a year earlier. Over the last 5 years it ranged from $55.94B to $135.53B, with a median of $83.91B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $102.80B | +20.9% |
| 2025 | Dec 31, 2025 | $85.02B | +3.7% |
| 2024 | Dec 31, 2024 | $81.99B | -18.0% |
| 2023 | Dec 29, 2023 | $99.99B | +22.3% |
| 2022 | Dec 30, 2022 | $81.76B | +15.8% |
| 2021 | Dec 31, 2021 | $70.62B | +26.8% |
| 2020 | Dec 31, 2020 | $55.70B | +29.3% |
| 2019 | Dec 31, 2019 | $43.10B | +0.3% |
| 2018 | Dec 31, 2018 | $42.96B | -1.4% |
| 2017 | Dec 29, 2017 | $43.59B | +2.7% |
| 2016 | Dec 30, 2016 | $42.44B | -32.0% |
| 2015 | Dec 31, 2015 | $62.40B | +37.9% |
| 2014 | Dec 31, 2014 | $45.24B | +40.1% |
| 2013 | Dec 31, 2013 | $32.29B | +100.0% |
| 2012 | Dec 31, 2012 | $16.15B | +222.2% |
| 2011 | Dec 30, 2011 | $5.01B | +90.7% |
| 2010 | Dec 31, 2010 | $2.63B | – |
See a number that looks wrong?